Clinical Trial Update: Safety and Performance Evaluation of ReWalk Reciprocating Gait Orthosis (RGO) [NA]

View source ↗

Summary

Completed clinical trial assessing safety and performance of the ReWalk Reciprocating Gait Orthosis (RGO) for individuals with paraplegia or spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paraplegia
• Spinal Cord Injury

Drugs mentioned

• ReWalk Reciprocating Gait Orthosis (RGO)

Snippet

Sponsor: ReWalk Robotics, Inc. | Conditions: Paraplegia, Spinal Cord Injuries (SCI) | NA | Status: COMPLETED